Cannabis News Box

Washington State University researchers recommend one puff of cannabis for depression

Washington State University researchers recommend one puff of cannabis for depression

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 20, 2018


Filed under Medical cannabis, News, Research

There has been much debate regarding the use of cannabis for depression, but researchers from Washington State University are clearing the smoke clouds. A team of researchers from WSU discovered that just a single puff of cannabis could relieve the symptoms of depression, stress and anxiety. The result...

Ohio’s impending comprehensive medical cannabis programs will create thousands of jobs

Ohio’s impending comprehensive medical cannabis programs will create thousands of jobs

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 18, 2018


Filed under Medical cannabis

Comprehensive medical cannabis programs will be offered by Ohio this fall, making it the 29th state to do so. The aim of this move is to ensure workers do not find themselves without coverage when they need it the most. A workforce is already being prepared to meet demand in the ever-expanding industry...

The VA may start researching medical cannabis

The VA may start researching medical cannabis

May 16, 2018


Filed under Medical cannabis, News, Showcase

Thor Benson / Cannabis News Box Contributor A bipartisan group of Congress members is currently pushing for a bill called the VA Medicinal Cannabis Research Act that would allow the VA to study the potential benefits of medical cannabis. Many veterans use cannabis to treat ailments like PTSD, chr...

Parents appeal to change laws on medical cannabis in New Mexico schools

Parents appeal to change laws on medical cannabis in New Mexico schools

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 14, 2018


Filed under Medical cannabis

Parents in New Mexico are pushing for the right to treat their young with cannabis on school property. The devoted parents claim that their kids are being administered cannabis for the treatment of various medical conditions. Despite this, THC  and CBD are listed as controlled substances under state and fed...

Missouri is on its way to approving medical cannabis

Missouri is on its way to approving medical cannabis

May 11, 2018


Filed under Medical cannabis, News

Thor Benson / Cannabis News Box Contributor It looks like Missouri may be one of the next states to legalize medical cannabis. A group called New Approach Missouri handed in a petition with over 370,000 signatures on it to the state government to get medical cannabis legalization on the ballot in November. Only 170,000 signatures ar...

Cannabis industry fights back after health agency proposes CBD ban in Texas

Cannabis industry fights back after health agency proposes CBD ban in Texas

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 8, 2018


Filed under Medical cannabis, News

Just one month since a Texas-based health agency suggested a potential crackdown on Cannabidiol (CBD), active cannabis industry advocates have been working hard to ensure CBD products remain on shelves statewide. It all started back in March when a draft plan to remove CBD products from shelves wa...

Global medical cannabis market set to be worth $28 billion by 2024

Global medical cannabis market set to be worth $28 billion by 2024

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 7, 2018


Filed under Global, Medical cannabis, News

Energias Market Research has released a report detailing the projected size of the global medical cannabis market in 2024. The report showed how the market will swell at a compound annual growth rate (CAGR) of 19.1 percent between 2018 and 2024. Estimated to be worth $8.28 billion in 2017, the global medical cannabis market will skyro...

MSU researchers discover how cannabis can be used to sustain mental stamina in HIV patients

MSU researchers discover how cannabis can be used to sustain mental stamina in HIV patients

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 5, 2018


Filed under Medical cannabis, Research

Patients with HIV could benefit from a specific chemical found in cannabis - Tetrahydrocannabinol (THC). This is according to researchers at Michigan State University, who published their findings in the Journal AIDS. According to the researchers, mental decline (a common symptom associated with ...

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 3, 2018


Filed under Medical cannabis

A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment Epidiolex will undergo FDA review this June. Things are looking hopeful, with a panel of 13 advisors...

Federal court rejects challenge to DEA classification, CBD oil remains a controlled substance

Federal court rejects challenge to DEA classification, CBD oil remains a controlled substance

May 2, 2018


Filed under Medical cannabis, News, Showcase

A panel of judges for the 9th U.S. Circuit Court of Appeals rejected the hemp industry's challenge of a DEA rule that would establish CBD oil as a "marihuana extract" and therefore, a controlled substance. The Hemp Industries Association and other hemp businesses claimed that the DEA's rule overstepped...

Low-income people can’t use medical cannabis in public housing, but that could change

Low-income people can’t use medical cannabis in public housing, but that could change

April 28, 2018


Filed under Medical cannabis, News

Thor Benson / Cannabis News Box Contributor Since cannabis is still illegal at the federal level, tenants of public housing are not allowed to use cannabis in their homes. Anyone caught doing so would risk losing a place to live. That’s highly problematic for tenants who need medical cannabis to treat...

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

Bethan Rose Jenkins, Cannabis News Writer/Editorial

April 19, 2018


Filed under Medical cannabis, News

Epidiolex, a cannabis-based treatment for epilepsy from GW Pharmaceuticals, received a positive review from staff at the Federal Drug Administration (FDA) on Tuesday. GW Pharmaceuticals provided “substantial evidence” to prove the drug’s suitability for treating two rare types of epilepsy. ...

Medical cannabis